Mermaid Medical Group® is excited to announce that TP Pivot Pro™ has officially received CE marking, confirming compliance with the EU’s health, safety, and environmental protection requirements.
From September 13-17, the Mermaid Medical team joined thousands of interventional radiology professionals at the annual CIRSE Congress in Barcelona.
Mermaid Medical Group® is proud to share that it has successfully passed its ISO 14001 audit with zero non-conformities identified.
Mermaid Medical Group® is pleased to announce an exclusive distribution agreement with MicroPort® for two cardiovascular devices: the VitaFlow Liberty™ Aortic Valve & Delivery System and Anchorman™ for LAAC procedures.
Mermaid Medical Group is excited to introduce its latest product addition: the Full Core Biopsy Device - designed with both optimal biopsy sample quality and user ergonomics in mind.
Mermaid Medical Group® is excited to announce that our partner, Danderyd Hospital in Sweden, is now offering microwave ablation (MWA) as a treatment for uterine fibroids, following the success of several clinical studies.
As of February 2025, Mermaid Medical is offering CPD-accredited workshops focused on Local Anaesthetic Transperineal Prostate (LATP) biopsy procedures.
Following the recent UKCA approval of TP Pivot Pro™, Prof. Hashim U. Ahmed has successfully performed the first European cases of transperineal prostate biopsies with the disposable needle guide designed by CIVCO Medical Solutions.
Mermaid Medical Group® Announces Exclusive Distribution Agreement for COBRA-OS® Device in the UK for REBOA Procedures with Front Line Medical Technologies Inc.